Find Aspartyl-alanyl-diketopiperazine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ampion, 110954-19-3, Da-dkp, R9chm391d5, 2-((2s,5s)-5-methyl-3,6-dioxopiperazin-2-yl)acetic acid, 2-[(2s,5s)-5-methyl-3,6-dioxopiperazin-2-yl]acetic acid
Molecular Formula
C7H10N2O4
Molecular Weight
186.17  g/mol
InChI Key
RVLCUCVJZVRNDC-IMJSIDKUSA-N
FDA UNII
R9CHM391D5

Aspartyl-alanyl-diketopiperazine
Aspartyl-alanyl-diketopiperazine is under investigation in clinical trial NCT03349645 (An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee).
1 2D Structure

Aspartyl-alanyl-diketopiperazine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[(2S,5S)-5-methyl-3,6-dioxopiperazin-2-yl]acetic acid
2.1.2 InChI
InChI=1S/C7H10N2O4/c1-3-6(12)9-4(2-5(10)11)7(13)8-3/h3-4H,2H2,1H3,(H,8,13)(H,9,12)(H,10,11)/t3-,4-/m0/s1
2.1.3 InChI Key
RVLCUCVJZVRNDC-IMJSIDKUSA-N
2.1.4 Canonical SMILES
CC1C(=O)NC(C(=O)N1)CC(=O)O
2.1.5 Isomeric SMILES
C[C@H]1C(=O)N[C@H](C(=O)N1)CC(=O)O
2.2 Other Identifiers
2.2.1 UNII
R9CHM391D5
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (2s,5s)-5-methyl-3,6-dioxo-2-piperazineacetic Acid

2. Ampion

3. Ap-013

4. Ap013

5. Da-dkp

2.3.2 Depositor-Supplied Synonyms

1. Ampion

2. 110954-19-3

3. Da-dkp

4. R9chm391d5

5. 2-((2s,5s)-5-methyl-3,6-dioxopiperazin-2-yl)acetic Acid

6. 2-[(2s,5s)-5-methyl-3,6-dioxopiperazin-2-yl]acetic Acid

7. 2-piperazineacetic Acid, 5-methyl-3,6-dioxo-, (2s,5s)-

8. Unii-r9chm391d5

9. Chembl4297349

10. Zinc33961611

11. Akos026716132

12. Db14940

13. Hy-107091

14. Cs-0027308

15. Q27288007

16. F2147-2995

17. 2-piperazineaceticacid,5-methyl-3,6-dioxo-,(2s,5s)-(9ci)

18. [(2s,5s)-5-methyl-3,6-dioxopiperazin-2-yl]acetic Acid

19. 1879938-60-9

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 186.17 g/mol
Molecular Formula C7H10N2O4
XLogP3-1.4
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass186.06405680 g/mol
Monoisotopic Mass186.06405680 g/mol
Topological Polar Surface Area95.5 Ų
Heavy Atom Count13
Formal Charge0
Complexity263
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty